| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |